STAAR Surgical Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" STAAR Surgical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View analyst ratings for STAAR Surgical or view top-rated stocks.

Wall Street analysts have given STAAR Surgical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but STAAR Surgical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for STAAR Surgical.

STAAR Surgical will be holding an earnings conference call on Wednesday, August 4th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 416-621-4642 with passcode "6090849".

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, May, 5th. The medical instruments supplier reported $0.20 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.22. The medical instruments supplier had revenue of $50.75 million for the quarter, compared to analysts' expectations of $43.50 million. STAAR Surgical had a trailing twelve-month return on equity of 10.93% and a net margin of 6.17%.
View STAAR Surgical's earnings history.

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, STAA shares have increased by 338.2% and is now trading at $122.75.
View which stocks have been most impacted by COVID-19.

STAAR Surgical updated its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $215 million-$217 million, compared to the consensus revenue estimate of $204.02 million.

5 brokerages have issued 1-year price objectives for STAAR Surgical's shares. Their forecasts range from $58.00 to $150.00. On average, they expect STAAR Surgical's share price to reach $106.00 in the next year. This suggests that the stock has a possible downside of 13.6%.
View analysts' price targets for STAAR Surgical or view top-rated stocks among Wall Street analysts.

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

Some companies that are related to STAAR Surgical include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Neogen (NEOG), ICU Medical (ICUI), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Meridian Bioscience (VIVO), Cerus (CERS), OraSure Technologies (OSUR), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of STAA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), The Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), The Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical's stock is owned by a variety of institutional and retail investors. Top institutional investors include TCW Group Inc. (0.20%), Oregon Public Employees Retirement Fund (0.03%), New Mexico Educational Retirement Board (0.02%) and 6 Meridian (0.00%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes.
View institutional ownership trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including TCW Group Inc.. Company insiders that have sold STAAR Surgical company stock in the last year include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical or view top insider-selling stocks.

STAA stock was bought by a variety of institutional investors in the last quarter, including 6 Meridian, New Mexico Educational Retirement Board, and Oregon Public Employees Retirement Fund.
View insider buying and selling activity for STAAR Surgical or or view top insider-buying stocks.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STAA stock can currently be purchased for approximately $122.75.

STAAR Surgical has a market capitalization of $5.76 billion and generates $163.46 million in revenue each year. The medical instruments supplier earns $5.91 million in net income (profit) each year or $0.35 on an earnings per share basis.

STAAR Surgical employs 147,000 workers across the globe.

The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

STAAR Surgical was founded in 1982.

The official website for STAAR Surgical is www.staar.com.

STAAR Surgical is headquartered at 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630.

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at (626) 303-7902 or via email at [email protected]